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Abstract 
Non-celiac gluten or wheat sensitivity (NCWS) is a “clinical entity induced by the ingestion of wheat leading to 
intestinal and/or extraintestinal symptoms that improve once the wheat-containing foodstuff is removed from the 
diet, and celiac disease and wheat allergy have been excluded”. This mostly accepted definition raises several points 
that remain controversial on this condition. In the present review, the authors summarize the most recent advances 
in the clinic and research on NCWS through an accurate analysis of different studies. We screened PubMed, Medline, 
Embase, and Scopus using the keywords “non-celiac gluten sensitivity”, “non-celiac wheat sensitivity”, and “diagno-
sis”. We would like to emphasize two main points, including (A) the controversial clinical and etiological aspects in 
different trials and experiences with particular attention to the Salerno criteria for the diagnosis of NCWS and (B) the 
histological aspects. The etiology of NCWS remains controversial, and the relationship with irritable bowel syndrome 
is obscure. Histologically, the duodenal mucosa may show a variable pattern from unremarkable to a slight increase 
in the number of T lymphocytes in the superficial epithelium of villi. The endorsement of this disease is based on a 
positive response to a gluten-free diet for a limited period, followed by the reappearance of symptoms after gluten 
challenge. The Salerno expert criteria may help to diagnose NCWS accurately. Social media and inaccurate interpreta-
tion of websites may jeopardize the diagnostic process if individuals self-label as gluten intolerant.
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Background
For more than 40  years, the polymorphic spectrum of 
presentation in clinical symptoms, laboratory data and 
histological characteristics of celiac disease has been 
compared to a “chameleon” [1, 2], and gastroenterologists 
seek refuge in further diagnostic tests or more compli-
cated levels of genetic diagnosis. If all these test results 
are negative, it is suggested to indicate that the patient 
may have so-called non-celiac wheat sensitivity (NCWS) 
(alternatively labeled non-celiac gluten sensitivity by 
some authors). In this review, the authors show recent 
advances and problems in the clinic and research on 
NCWS and report their experience in facing clinical and 
histological doubts in this field.
Methodology of the search strategy
We performed a literature search in PubMed (http://
www.ncbi.nlm.nih.gov/pubme d/), Medline, Embase, Sco-
pus, and Google Scholar (up to April 30, 2020) using the 
following search terms in the title and abstract: ‘Non-
celiac gluten sensitivity’ or ‘Non-celiac wheat sensitivity’ 
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and ‘diagnosis’. We searched the key words alongside the 
following limitations: English language, human studies, 
and clinical trials. To qualify for inclusion (“inclusion 
criteria”), studies had to be randomized controlled trials 
(RCTs). Only articles that were published in English-lan-
guage peer-reviewed journals were included. Reference 
lists and reviews were further hand-searched to identify 
RCTs.
Results and discussion
A total of 26 studies were found to be relevant for diag-
nosis and histology, but this number was expanded to 
include several aspects that are crucial for the narra-
tive section of the review [3–71]. RCTs and clinical tri-
als (CTs) were specifically included. Exclusion criteria 
included studies that were duplicated, showed overlap-
ping, and, according to the authors, were considered 
nonrelevant.
Although NCWS is often considered a very recently 
discovered clinical condition, it was known more than 
40 years ago, when Ellis and Linaker presented the case 
of a 43-year-old patient with diarrhea in the absence of 
celiac disease, who showed a marked improvement with 
the removal of gluten from the diet [72]. For forty-two 
years, the research started to define this entity better, 
but we are still struggling to arrive at the goal of a clear 
definition from the clinical, laboratory, and histological 
point of view. The introduction of the gluten challenge 
triggering gastrointestinal symptoms following a tightly 
adherent gluten-free diet (GFD) in individuals without 
celiac disease reinforced some observations of the 1980s 
[73]. The idea is that either gluten or wheat may trigger a 
non-GSE celiac symptomatologic pattern [18, 70]. In this 
paper, we preferred the use of the label “non-celiac wheat 
sensitivity” (NCWS), as we consider the real trigger of 
the symptoms in these patients when they eat wheat to 
still be undefined. In any case, the label of “non-celiac 
wheat sensitivity” effectively reflects our poor under-
standing of this condition and the inability to answer our 
patients and colleagues correctly [18, 70, 72–76].
In a world dominated by the Internet, it is easy to 
spread the message that one is better off with a GFD 
even if one does not have celiac disease or a sensitivity 
to wheat [77–79]. Thus, a plethora of individual reports 
and experiences have saturated several channels of infor-
mation and are showing that ordinary people as well as 
nonspecialists have found the culprit to be gluten, or 
preferably wheat, and are choosing a GFD as a lifestyle. 
Apart from the diabetogenic risk of selecting a GFD if it 
is not recommended, a GFD has a crucial or nonnegligi-
ble effect on one’s financial budget, specifically for people 
with low incomes [41, 80, 81]. However, there are actual 
subjects who self-report the onset of gastrointestinal 
symptoms after consuming some food containing gluten 
or wheat, and this symptomatology remits after “gluten/
wheat” exclusion and recurs following the reintroduction 
of “gluten/wheat” [19].
Thirty years after its initial description, the diagnosis 
of NCWS remains sophisticated and vaguely accepted. 
Currently, to make this diagnosis, we must have a symp-
tomatic reaction to gluten or wheat-containing food in 
a patient who has been ruled out as having either celiac 
disease or wheat allergy. In a world where social media 
is dominating, we often experience individuals who “feel” 
better applying a GFD to their life either personally or 
through Internet blogs [77–81].
Gastroenterology, like medicine, is not perfect, and sev-
eral pathologies are still challenging to correctly define. A 
similar example is that of irritable bowel syndrome (IBS), 
which, despite the Roma IV criteria [82], is sometimes 
difficult to discern from atypical or attenuated forms of 
inflammatory bowel disease or celiac disease [83].
Conflicting data from clinical trials
To date, several CTs and RCTs addressing the NCWS 
issue with different designs, controversial results, and 
numerous limitations have been published. In Table  1, 
most of the RCTs on NCWS are listed chronologically 
with some of the restrictions [14, 61, 84–92]. Conflicting 
results of clinical trials are a problem but probably not 
the only one. In examining some of these trials, we high-
light these conflicts, but the overemphasis may also be 
a problem. A randomized, double-blind study reported 
that dietary gluten, provided in the context of low FOD-
MAPs (fermentable oligosaccharides, disaccharides, 
monosaccharides, and polyols), induced symptoms com-
pared to placebo in patients who had no histological or 
serological evidence of celiac disease [93]. The Finnish 
study performed at the Department of Internal Medicine 
of the Tampere University Hospital evaluated 93 consec-
utive adults from health centers spontaneously reporting 
abdominal symptoms after consumption of cereals. Nine 
percent of patients had celiac disease, of which 17 had an 
increased density of gamma delta (γδ) + intraepithelial 
lymphocytes (IELs) without atrophy.
On the other hand, only 8% of patients showed evi-
dence of celiac disease, i.e., both an increase in γδ + IELs 
and the presence of celiac disease-type HLA. Approxi-
mately 20% (one in five) had one or more positive allergy 
tests for cereals. In the patients who adopted a GFD, all 
abdominal symptoms were alleviated. However, method-
ological deficiencies have been delineated [94].
The New Zealand Asthma and Allergy Cohort Study 
Group reveals how influential the culture in our soci-
ety is on the choice of a GFD without a proper diag-
nosis [95]. In only 1% of the 916 enrolled children, 
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physician-diagnosed celiac disease was pronounced. 
Approximately 5% of these children avoided only gluten.
Interestingly, the analysis of the predictors of gluten 
avoidance in children without doctor-diagnosed celiac 
disease suggests critical regional differences in com-
munity belief or medical practice considering that the 
Christchurch census data reveal that 80% are of European 
ethnicity.
A possible pitfall, in some trials, can be related to the 
heterogeneity of subjects. In some tests, a mixed popu-
lation of patients with IBS who likely respond to many 
dietary exclusion diets, including placebo, has been 
identified. Methodological issues related to short wash-
out periods between challenges contribute to compli-
cating the interpretation of results. Recently, Dale et al. 
[92] failed to show symptomatic responses to gluten 
when the challenge was introduced in a blinded fash-
ion. Dale’s study had a rigorous double-blind placebo-
controlled design, but FODMAPs were not explicitly 
removed from the treatment. Dietary management 
is probably crucial. They supposed that the influence 
of community belief and culture plays a role that was 
unknown in the twentieth century or before [96]. On 
the other hand, to overcome the heterogeneity of the 
patient population with suspected NCWS included in 
dietary trials, the two most important studies that con-
cluded that FODMAPs but not gluten cause symptoms 
[61, 85] planned exclusion criteria, which excluded 
most of the “real” NCWS patients. To overcome the 
possible overlap with the initial stage of celiac disease 
(the so-called “celiac lite”), the authors of both of these 
studies excluded subjects with IEL count > 25/100 EC 
(Marsh 1 lesion) who had HLA haplotypes predispos-
ing to celiac disease (DQ2 and DQ8) and some other 
pathological conditions mimicking the initial morpho-
logical phase of GSE. Although these rigorous exclu-
sion criteria must be considered excellent with respect 
to the “celiac lite” problem, it must be emphasized that 
the majority of the subjects suffering from NCWS had 
an intraepithelial infiltration of the duodenal mucosa; 
furthermore, approximately 50% of the NCWS sub-
jects display DQ2 or DQ8 haplotypes, a percentage that 
Table 1 Randomized clinical trials
References Design N Dose Control Treatment Wash-out Run-in Challenge Outcome
Biesiekierski [84] DB-RCT 34 16 g/days GF bread or 
muffin





Carroccio [14] DBPC 50 10 g/days Xylose 2 weeks 1 weeks 4 weeks elimi-
nation
Capsules wheat GS-Symptoms 
triggered by 
wheat
Biesiekierski [85] DB, cross-over 22 16 g/days Gluten-low (2 g/
days), placebo







Di Sabatino [86] DBPC, cross-
over





DBPC 72 50 g/days Sachet powder 
rice flour





Zanini [88] DBPC, cross-
over
35 10 g/days Sachet GF-flour 10 days 2 weeks GFD > 3 months Sachet gluten IBS-triggered by 
gluten chal-
lenge
Zanwar [89] DBPC 60 No data GF bread 4 weeks No data GFD 1 months Bread IBS-triggered by 
gluten chal-
lenge
Elli [90] DBPC, cross-
over





Open challenge 56 120 g/days No control 3–14 days No data GFD 16 months Bread GS-Symptoms 
triggered by 
wheat
Skodje [61] DBPC, cross-
over
59 5.7 g/days GF low FOD-
MAP muesli





Dale [92] DBPC 20 11 g/days Rice starch 4 days 3 days GFD 6 weeks Muffin gluten IBS-triggered by 
gluten chal-
lenge
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is higher than that reported in the general population. 
Thus, the exclusion criteria of those studies excluded 
the “inflamed patients”, i.e., those who were more likely 
to suffer from a real NCWS. Regarding mucosal inflam-
mation in patients with NCWS, recent studies based on 
confocal endoscopy have demonstrated in a large per-
centage of subjects with IBS that wheat administration 
on the mucosa determined the break of the tight junc-
tions and lymphocytic infiltration. Numerous patients 
with IBS have atypical food allergies, which are not 
associated with immunoglobulin E [97]. Thus, once 
again, there is evidence that duodenal mucosal inflam-
mation, although in the absence of villi atrophy, charac-
terizes NCWS.
Moreover, the two most common GSE mimick-
ers, excluding inflammatory bowel disease, are gastric 
Helicobacter pylori (H. pylori) infection and medica-
tions, especially nonsteroidal anti-inflammatory drugs 
(NSAIDs) or proton-pump inhibitors (PPIs) and an 
increased IEL count is observed in the duodenum of 
patients with H. pylori gastritis [98].
Since the first report of NCWS in 1978 [72], the 
approach to this entity has been troubled by scientific 
and nonscientific reports revealing considerable debate 
as well as a conspicuous conflict of interest. The termi-
nology “gluten sensitivity” (GS) infers an immunologic 
reactivity to “gluten”. Thus, gluten sensitivity that may 
be triggered or not triggered by gluten includes celiac 
disease. It indeed enhances confusion. Gastrointesti-
nal and nutritionist professional meetings have dis-
cussed this condition since early 2000 [19, 99, 100]. In 
the 2012 report assembling scientists and physicians 
from several countries and issued by the Center for 
Celiac Research, located at the University of Maryland 
School of Medicine, Baltimore, United States, Sapone 
et al. [99] defined NCWS (or GS) as a reaction to gluten 
in which both allergic and autoimmune mechanisms 
have been accurately excluded. The report empha-
sizes the diagnosis of exclusion, but one of the major 
problems in celiac research is the accuracy of the diag-
nosis. Of course, there are clear-cut cases of celiac dis-
ease, but a few instances of IELs may easily cross the 
borders of the categories. Numerous gastrointestinal 
pathologists know the “difficult” cases that need to be 
discussed at the multidisciplinary team meetings. In a 
Canadian report, Armstrong et al. [101] indicated that 
subjects harboring NCWS should have typical duode-
nal histopathology and negative specific celiac serology, 
but some nonspecific biomarkers such as antiglia-
din antibodies may be positive biochemically, but the 
implementation of a GFD helping to resolve the symp-
tomatology obscures the boundaries with patients with 
celiac disease.
Current criteria for NCWS diagnosis
To make the NCWS diagnosis, we must have a sympto-
matic reaction to wheat-containing food in a patient who 
has been ruled out as having either celiac disease or wheat 
allergy. Catassi et al. proposed a 2-step algorithm at the 
Salerno conference [18, 20]. Once a symptom-accompa-
nying patient presents to the physician, celiac disease and 
wheat allergy need to be ruled out first, and a GFD is sug-
gested for six weeks. Skin prick testing, serum IgE testing 
and oral food challenges remain the current gold stand-
ard tests for anaphylactic (immediate) type food allergies, 
while serum IgG testing, electrodermal testing, cytotoxic 
testing, provocation/neutralization, and applied kinesi-
ology are unproven unaccepted methods to diagnose it 
[102]. The symptoms of the patient are scored according 
to the global symptoms rating scale before and following 
the six weeks of GFD. If the patient has a resolution of 
the symptoms after the GFD, the diagnosis of NCWS is 
made; otherwise, the patient requires additional investi-
gations. After this 1st step, the 2nd step encompasses a 
double-blind placebo-controlled challenge with a crosso-
ver design. This study design is needed for the confirma-
tion of the diagnosis of NWGS in patients responding to 
treatment with a GFD [20, 42]. According to the Salerno 
criteria [20], there is a 1-week challenge, which involves 
the administration of capsules containing 8  g of gluten 
with at least 0.3  g of amylase trypsin inhibitors (ATIs) 
embedded in a FODMAP-free vehicle and a gluten-free 
placebo. The challenge should follow a 1-week wash-out. 
It seems that a subtype may be delineated, incorporating 
patients with IBS-type symptoms and labeled “gluten or 
wheat-sensitive IBS” [18].
Is there a role for mucosal histology in the NCWS 
diagnosis?
The histopathology of NCWS is even still, like the clini-
cal and laboratory features, a point of debate, and in 
many cases, there is extreme confusion. The fundamen-
tal assumption for a correct histopathological evalu-
ation is the clinical and methodological assumption, 
namely, a precise selection of patients based on clini-
cal and laboratory characteristics [20]. Furthermore, 
an exact number of correctly oriented biopsies (greater 
than or equal to 4) as in the case of celiac disease in the 
second duodenal portion and the bulb need to be car-
ried out. The orientation of the same biopsies in which 
the use of cellulose acetate filters that are already cut 
for this purpose is also recommended to avoid false 
atrophies and imprecise T lymphocyte counts, and the 
role of some infections, such as in Helicobacter pylori-
related gastritis or infestations caused by Giardia Lam-
blia or Cryptosporidium, which can cause an increased 
number of IELs (intraepithelial lymphocytosis, IEL) 
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without architectural abnormalities, cannot be suffi-
ciently emphasized [98, 103–109]. Moreover, several 
drugs and autoimmune disorders produce the same his-
tology findings. Other reported conditions associated 
with an increased number of IELs include Hashimoto 
thyroiditis, Graves’ disease, rheumatoid arthritis, pso-
riasis, multiple sclerosis, systemic lupus erythematosus 
and common variable immune deficiency.
Most of the work on the topic of NCWS considers the 
duodenal mucosa healthy or almost healthy, and without 
indicating morphological aspects that are useful when 
suspecting the condition, it can be considered useless. 
The only experience, to our knowledge, that may sug-
gest a morphological framework was the cooperative 
work of the Brescia and Palermo groups [110–112] and 
the crucial Brescia experience in which, based on care-
ful clinical and laboratory selection based on the Salerno 
criteria [20], biopsies were performed in 18 patients and 
10 controls.
The morphological elements evidenced in the Brescia 
experience are as follows:
A A “nearly” standard number of T lymphocytes (< 25 
for 100 epithelial cells)
B A peculiar disposition of T lymphocytes in a small 
“cluster” of 4 or 5 cells in the superficial epithelium
C The linear distribution of T lymphocytes in the 
deeper part of the lamina propria of the mucosa over 
the muscularis mucosae  (lamina muscularis 
mucosae)
D An increased number of eosinophils in the lamina 
propria (> 5 cells per high-power field, HPF) (Fig. 1).
The presence of eosinophils may suggest a condition 
similar to food allergies. Further prospective studies are 
needed to confirm the Brescia-Palermo findings and 
their specificity. Although the term “nearly” may not 
satisfy physicians, the heterogeneity of studies and data 
have indicated that at least some of the subjects suffer-
ing from NCWS may have increased IELs [39, 83, 113]. 
Another point that deserves attention in future studies 
is the “site of intestinal inflammation” in NCWS. Almost 
all the reviews, to date, have focused on the duode-
nal mucosa, probably due to the need to exclude celiac 
disease in a patient who reports symptoms induced by 
wheat ingestion. However, it must be remembered that 
most patients with NCWS have an IBS-like clinical pres-
entation, suggesting “clinical involvement” of the colon. 
Fig. 1 a–c Normal villi with T lymphocytes in the normal range (< 25 for 100 epithelial cells). a–b Hematoxylin and eosin staining × 10; c CD3 
immunostaining × 10 original magnification. d–f: Eosinophils in the lamina propria (arrows). Hematoxylin and eosin staining × 100 original 
magnification. g–i Linear distribution of T lymphocytes in the deeper part of the mucosa over the muscularis mucosae, the outermost layer of 
the mucosa (arrows). CD3 immunostaining g × 10 original magnification h–i × 40 original magnification. j–l Cluster of 5–6 T lymphocytes in the 
superficial epithelium of villi (yellow rectangles) CD3 immunostaining × 100 original magnification
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According to the clinical presentation, a recent study of 
the Palermo and Brescia groups showed a relevant eosin-
ophilic infiltration in the rectal mucosa of patients with 
NCWS, which was more intense in the rectal than in the 
duodenal mucosa. Interestingly, the numbers of eosino-
phils in the duodenal mucosa were higher in patients 
with NCWS with dyspepsia than in patients with NCWS 
without upper digestive tract symptoms [112]. Overall, 
these data could indicate that NCWS is an inflammatory 
condition that involves the entire gastrointestinal tract 
and that the site of dominant inflammation drives spe-
cific clinical symptoms.
Diagnostic challenges
As pediatricians, gastroenterologists, and pathologists, 
it is mandatory to exclude other diseases, such as auto-
immune conditions, lactose and fructose intolerance, 
inflammatory bowel disease (ulcerative colitis, Crohn’s 
disease, indeterminate colitis), and pancreatic insuffi-
ciency before the diagnosis of NCWS is proposed [20]. 
The likeness of the clinical presentation of celiac disease 
and NCWS may be striking. Although some may con-
sider NCWS and celiac disease two “sisters” with similar 
features, there are substantial differences between these 
two conditions, and probably, only a minor percentage of 
patients with NCWS suffer from a condition near celiac 
disease; these probably include the NCWS cases among 
first-degree relatives of patients with celiac disease. Fur-
thermore, in some cases, discernment from psychoso-
matic symptoms may be impossible. Apart from lethargy, 
extraintestinal symptoms may include fatigue, skin rash, 
gynecologic troubles (recurrent vaginitis and cystitis in 
the potential setting of endometriosis), headache, joint 
and muscle pain (fibromyalgia or fibromyalgia-like syn-
drome), leg or arm numbness, and anemia as well as 
neurologic disorders such as depression, anxiety, and 
psychosis. It seems that a GFD is particularly success-
ful in improving these extraintestinal manifestations [42, 
102, 112].
Pathogenetic hypotheses
The lack of clarity in the definition, as well as the pres-
ence of controversies in clinical trials, suggest that the 
etiopathogenesis remains poorly understood. Alterations 
in intestinal permeability, as well as abnormal motility 
and stimulation of the gut, have been postulated. Gliadin 
can trigger hypercontractility of smooth muscle and cho-
linergic nerve dysfunction in some animal models (e.g., 
mice) expressing the human leukocyte antigen (HLA)-
DQ8 genes without causing duodenal atrophy of the 
duodenal mucosa [101, 114]. In particular, gut dysfunc-
tion has been demonstrated in gluten-sensitive HLA-
DQ8 transgenic mice. In a study, acetylcholine release, 
small intestinal contractility, and epithelial ion transport 
were measured in HLA-DQ8 mice sensitized and gav-
aged with gliadin three times per week for three weeks 
[115]. Increased acetylcholine release from the myenteric 
plexus, muscle hypercontractility, and increased active 
ion transport were demonstrated in sensitized mice. 
Changes in muscle contractility were normalized in DQ8 
mice after gluten withdrawal. Recruitment of IELs, mac-
rophages, and FOX-P3 was observed in sensitized mice in 
the absence of intestinal atrophy. HLA-DQ6 controls did 
not exhibit the abnormalities in gut function observed 
in DQ8 mice. Overall, these experimental data provide 
evidence that “gluten sensitivity” in HLA-DQ8 mice may 
lead to altered water movements and dysmotility. Some 
divergences in intestinal permeability in NCWS have also 
been demonstrated in celiac disease [116, 117].
Concerning the potential trigger protein and nonpro-
tein fractions in the wheat kernel, gluten constitutes the 
most abundant protein fraction in wheat (~ 80%). In com-
parison, ATIs account for approximately 3% [118], and 
other proteins (e.g., agglutinin) in wheat germ account 
for the remainder. As quoted above, there is no proof that 
gluten is the real culprit in NCWS. On the other hand, 
ATIs could be an “interesting” pathogenetic candidate. 
Although different polymorphisms of Toll-like recep-
tor 4 (TLR4) have not been found in celiac disease [119], 
it seems that the TLR4-MD2-CD14 complex may be a 
potent activator of innate immune responses in mono-
cytes, macrophages, and dendritic cells through Toll-like 
receptors and may play a role in NCWS [60, 120, 121]. 
MD2 is a secreted protein that interacts with TLR4, binds 
the lipid A moiety of lipopolysaccharides, and facilitates 
the creation of TLR4 dimers that are intimately required 
for downstream signaling and activation of the NF-κB 
(nuclear factor kappa light chain enhancer of activated B 
cells) pathway, while CD14 is a glycosyl-phosphatidylin-
ositol (GPI)-linked protein found on the cell membrane 
in lipid rafts (microdomains at the plasmatic membrane 
with definite lipid and protein composition) and func-
tions to transfer lipopolysaccharides from the bacterial 
cell wall to the MD2/TLR4 complex [122].
Furthermore, wheat is a rich source of the fructose 
molecule polymer fructooligosaccharides (FOS), and this 
has been suggested to trigger symptoms in some patients 
with IBS symptomatology. However, it must be stressed 
that the malabsorption of short-chain carbohydrates can 
determine intestinal symptoms, whereas it is challenging 
to link this mechanism with the frequent extraintestinal 
symptoms reported by patients suffering from NCWS.
Social and media aspects in choosing a GFD
It is entirely premature to consider the rate of this con-
dition because the criteria used for diagnosing it are still 
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at the initial stages of the process (13). There are incred-
ible difficulties in assessing the prevalence of NCWS 
correctly because most of the patients are diagnosed 
by practitioners or by the patients themselves. After all, 
the information is overwhelming on social media (see 
below). A New Zealand study highlights some concern-
ing data showing that despite only 1% of children having 
celiac disease, 5% are on a GFD [95]. In the United States, 
a 0.55% prevalence rate of subjects on a self-reported 
GFD of 7762 persons (unselected) aged six years or older 
between 2009 and 2010 was found [123]. This rate is 
the lowest prevalence of self-reported NCWS in the lit-
erature, and it must be emphasized that this study was 
performed before the current interest and knowledge 
about NCWS. On the other hand, NCWS may affect up 
to 6% of the U.S. population [123] and worldwide up to 
13% if self-reported NCWS is considered [124, 125]. On 
the other hand, these data may not be reliable because 
of the subjectivity of some symptoms, the nonmedical 
approach, and the lack of a trustworthy biomarker esti-
mating an exact prevalence rate [126].
In both Europe and North America, adopting a GFD 
has become increasingly popular, and interest in a GFD 
has been growing from 2004 to 2018 (https ://trend 
s.googl e.com/trend s), eclipsing the low-carbohydrate 
diet and fat-free diets. The so-called “clean diets” are 
bombarding social media and news outlets, and the GFD 
market is incredibly lucrative. Adopting a GFD and not 
having NCWS may be disastrous for the organism if a 
correct balance of proteins, carbohydrates, and lipids is 
not applied. Selecting a GFD and having NCWS may be 
the only choice if other conditions have been adequately 
ruled out by an expert healthcare practitioner. Because 
derivatives of gluten-rich grains are relevant sources of 
nutrients in the general diet, their exclusion from the 
diet could potentially have significant effects on nutri-
tional status. For example, in patients with NCWS on 
a wheat-free diet, a higher frequency of osteopenia and 
osteoporosis than in controls has been reported [127]. In 
addition to the likelihood of nutritional deficiencies fol-
lowing a nonsupplemented and unsupervised GFD, this 
dietary restriction has been shown to disturb the richness 
and composition of gut microbiota. At the end of the 2nd 
decade of this 3rd millennium, the number of individu-
als embracing a GFD appears to be much higher than the 
projected number of patients with celiac disease, and the 
growth has been exponential for several countries. Much 
of the world’s manufacture of wheat is consumed after 
it has been processed into bread, several baked goods, 
noodles, and pasta, while in the Middle East and North 
Africa, bulgur and couscous are the main products. The 
choice of GFD fueled a global market of gluten-free prod-
ucts approaching $2.5 billion (United States) in global 
sales in 2010. Nevertheless, this trend is not going to stop 
because of social media and scientific or pseudoscien-
tific reports of gluten being the culprit for both intesti-
nal and extraintestinal diseases, such as attention deficit 
hyperactivity disorder, autism, mood disorders and psy-
chosis [17, 19, 41, 128–134]. This trend is reinforced by 
the belief that, along with celiac disease, other condi-
tions related to the ingestion of gluten have emerged. The 
Mediterranean diet implies an abundance of plant foods, 
including fruits, vegetables, whole grains, nuts, and leg-
umes, which are minimally processed, seasonally fresh, 
and grown locally. Olive oil, as the principal source of fat, 
cheese, and yogurt, is consumed daily in low to moderate 
amounts. Although the Mediterranean diet is probably 
now the best diet to avoid cardiovascular diseases as well 
as rheumatic and oncological diseases, GFD is embraced 
with the spirit of madness, evoking problems related to 
gluten that have no substantial background [135–139]. 
Doubtless, the introduction of gluten-containing grains, 
which occurred approximately 10,000 years ago with the 
advent of agriculture, embodies an evolutionary chal-
lenge of human beings. It obviously created the condi-
tions for human diseases related to gluten exposure to 
be presented. Although cofactors in triggering these dis-
eases are largely unknown, the balance of a diet for chil-
dren, youth, and adults in the 3rd millennium is full of 
pitfalls because of food processing and industry interests. 
The importance of excluding wheat from the Mediter-
ranean diet in patients without celiac disease may have 
consequences for the gut microbiome, as evidenced in 
some studies of patients with inflammatory bowel dis-
ease using a different diet [137]. At first glance, the South 
Asian diet may be healthier because of the lack of bloat-
ing complaints [140, 141]. However, the diffusion of noo-
dles in North China substantially compares to the use of 
wheat in the Western region. Table  2 shows the advan-
tages and disadvantages of choosing a GFD for a patient 
Table 2 Conditions that  may improve or  worsen in  non-
celiac symptomatic subjects by adopting a gluten-free diet
Improve Worsen
Atopy Coronary artery disease
Attention deficit-hyperactivity disorders Fiber deficiency
Autism spectrum disorder Financial burden
Endometriosis Hyperglycemia
Fibromyalgia Hyperlipidemia
Irritable bowel syndrome symptoms Micronutrient deficiency
Obesity/overweight Social deprivation
Psychosis and schizophrenia Social impairment
Social inclusion Social restriction
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not suffering from “typical” wheat-related diseases. This 
table is far from perfect but collects the experience of 
the authors and data from the literature. Substantially, 
the downgrading of the difficulties in this table is mostly 
influenced by community factors, which are primarily 
associated with social media influences. The persuasive 
power of social media may skew the decision of the sin-
gle individual in lifestyle choices [81, 142–146]. The influ-
ence on social behavior can be challenging with social 
impairment; these individuals can experience restriction 
and even deprivation. This challenge as well as the igno-
rance of medical research may shape the appropriateness 
of choices of future generations.
Conclusions
The number of reports on GFD and the harmful effects of 
gluten has been increasing tremendously in social media 
and scientific journals over the past ten years. Although 
the Salerno criteria helped to delineate the NCWS group 
better, there is still much work to do in this field. In this 
review, the clinical and histological elements evidenced 
in the experience of two major Italian centers (Palermo 
and Brescia) and one Canadian center (Edmonton) have 
been characterized, but we must affirm that no picture 
can be considered pathognomonic. Unfortunately, we 
still have an inaccurate histologic marker for NCWS 
diagnosis, and duodenal biopsy is undoubtedly useful to 
rule out a seronegative celiac disease but not for a “posi-
tive diagnosis” of NCWS. From a clinical point of view, 
we agree that NCWS is not the only cause of IBS, which 
is a complex, multifactorial condition. Wheat contains 
many potentially immunogenic proteins in addition to 
gluten, and nonprotein fractions could trigger symptoms 
in patients with functional disorders. Beyond functional 
disorders, future studies will define whether any wheat 
component can be implied in the pathogenesis of inflam-
mation and autoimmune diseases.
Similarly, studies investigating biomarkers and epige-
netics are needed to identify the subpopulations that will 
benefit most from a GFD. From a social point of view, 
although most individuals consuming a wheat-containing 
diet do not have adverse reactions, social influence on 
nutrition has reshaped some aspects of the dietary hab-
its of our society and probably forced them to consume a 
wheat-free diet.
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